Patten & Patten’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,400
Closed -$210K 329
2025
Q1
$210K Sell
7,400
-103
-1% -$2.92K 0.01% 307
2024
Q4
$312K Sell
7,503
-1,510
-17% -$62.8K 0.02% 258
2024
Q3
$602K Sell
9,013
-181
-2% -$12.1K 0.04% 205
2024
Q2
$1.09M Sell
9,194
-300
-3% -$35.6K 0.08% 156
2024
Q1
$1.01M Buy
9,494
+671
+8% +$71.5K 0.07% 159
2023
Q4
$877K Buy
8,823
+235
+3% +$23.4K 0.07% 157
2023
Q3
$887K Sell
8,588
-907
-10% -$93.7K 0.08% 149
2023
Q2
$1.15M Sell
9,495
-585
-6% -$71.1K 0.1% 138
2023
Q1
$1.55M Sell
10,080
-51
-0.5% -$7.83K 0.14% 113
2022
Q4
$1.82M Sell
10,131
-745
-7% -$134K 0.17% 99
2022
Q3
$1.29M Sell
10,876
-574
-5% -$67.9K 0.12% 119
2022
Q2
$1.64M Sell
11,450
-4
-0% -$572 0.14% 106
2022
Q1
$1.97M Sell
11,454
-50
-0.4% -$8.61K 0.14% 109
2021
Q4
$2.92M Sell
11,504
-160
-1% -$40.6K 0.2% 87
2021
Q3
$4.49M Sell
11,664
-275
-2% -$106K 0.34% 76
2021
Q2
$2.81M Buy
11,939
+2,449
+26% +$575K 0.21% 87
2021
Q1
$1.24M Buy
9,490
+1,120
+13% +$147K 0.1% 130
2020
Q4
$874K Buy
8,370
+110
+1% +$11.5K 0.08% 153
2020
Q3
$584K Buy
8,260
+85
+1% +$6.01K 0.06% 166
2020
Q2
$525K Buy
8,175
+80
+1% +$5.14K 0.06% 165
2020
Q1
$242K Buy
+8,095
New +$242K 0.03% 205